KYRA HUGHES: Open Payments
NPI 1891340394 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 44 payments from 16 companies in 2025. Trend: 2023 $1,794 · 2024 $1,010 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $183 |
| AstraZeneca Pharmaceuticals LP | 6 | $154 |
| Galderma Laboratories, L.P. | 2 | $97 |
| GENZYME CORPORATION | 5 | $86 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $71 |
| Amgen Inc. | 3 | $66 |
| CSL Behring | 3 | $59 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Grifols USA, LLC | 1 | $31 |
Products named: NUCALA, TEZSPIRE, NEMLUVIO, AIRSUPRA, NEFFY, DUPIXENT, Andembry, ALVESCO.
Industry payments across IN — which companies pay providers there.
